DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Clinical trial NCT05786716 · RECRUITING

Trial details

NCT number: NCT05786716
Sponsor: Cancer Research UK
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Haematological Malignancy Colorectal Neoplasms Urinary Bladder Neoplasm Gallbladder Neoplasms Salivary Gland Neoplasm Lung Neoplasm Pancreatic Neoplasm Ovarian Neoplasms Prostatic Neoplasm Skin Neoplasm Solid Tumour

Start date: 2023-03-07
Primary completion: 2029-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.